Key Takeaways
- The prevalence of Fetal Alcohol Syndrome (FAS) in the United States is estimated at 0.2 to 1.5 cases per 1,000 live births based on active surveillance
- Globally, FAS prevalence is approximately 2 per 1,000 live births according to a 2017 systematic review
- In South Africa, FAS prevalence reaches up to 68.5 per 1,000 children in some communities per 2001 study
- Maternal alcohol consumption during pregnancy increases FAS risk by 7.5-fold if binge drinking
- Binge drinking (4+ drinks) in first trimester raises FAS risk to 13.8% vs 1.4% no alcohol
- Genetic variants in ALDH2 gene increase FAS susceptibility by impairing alcohol metabolism
- Distinctive facial features (short palpebral fissures <3.3cm) occur in 90% of FAS cases
- Growth retardation (height/weight <10th percentile) present in 85-95% of FAS children
- Microcephaly (head circumference <3rd percentile) in 75% of diagnosed FAS
- Brain volume reduction of 8-10% in FAS children vs controls
- Corpus callosum agenesis/hypoplasia in 40-80% of prenatal alcohol exposed with FASD
- Hippocampal volume 10-15% smaller in FAS adolescents
- Public health campaigns reduce prenatal alcohol use by 20-30%
- Warning labels on alcohol reduce self-reported drinking by 11% in pregnancy
- Brief interventions (1-2 sessions) cut alcohol use by 50% in pregnant women
Fetal Alcohol Spectrum Disorders, including FAS, continue to affect a significant number of births annually, but remain among the most preventable neurodevelopmental conditions through increased public understanding and proactive community support systems as we move toward 2026.






